Using ABP, we could identify a reduction in mGluR5 binding estimated by ABP in Alzheimer's dementia in the hippocampus and the amygdala, which could be due to either losses in postsynaptic binding sites or adaptive processes in Alzheimer's disease. This evidence concerns the gene GRM5 and early-onset autosomal dominant Alzheimer disease.